Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 385

1.

The Effect of Hearing Aid Use on Cognition in Older Adults: Can We Delay Decline or Even Improve Cognitive Function?

Sarant J, Harris D, Busby P, Maruff P, Schembri A, Lemke U, Launer S.

J Clin Med. 2020 Jan 17;9(1). pii: E254. doi: 10.3390/jcm9010254.

2.

Rates of age- and amyloid β-associated cortical atrophy in older adults with superior memory performance.

Dang C, Yassi N, Harrington KD, Xia Y, Lim YY, Ames D, Laws SM, Hickey M, Rainey-Smith S, Sohrabi HR, Doecke JD, Fripp J, Salvado O, Snyder PJ, Weinborn M, Villemagne VL, Rowe CC, Masters CL, Maruff P; AIBL Research Group.

Alzheimers Dement (Amst). 2019 Aug 12;11:566-575. doi: 10.1016/j.dadm.2019.05.005. eCollection 2019 Dec.

3.

SuperAging: Current findings yield future challenges-A response to Rogalski and Goldberg.

Dang C, Maruff P.

Alzheimers Dement (Amst). 2019 Aug 12;11:562-563. doi: 10.1016/j.dadm.2019.05.004. eCollection 2019 Dec. No abstract available.

4.

Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer's Disease.

Yassi N, Hilal S, Xia Y, Lim YY, Watson R, Kuijf H, Fowler C, Yates P, Maruff P, Martins R, Ames D, Chen C, Rowe CC, Villemagne VL, Salvado O, Desmond PM, Masters CL.

J Alzheimers Dis. 2020;73(3):897-907. doi: 10.3233/JAD-191028.

PMID:
31884485
5.

Identification of Pre-Clinical Alzheimer's Disease in a Population of Elderly Cognitively Normal Participants.

van Havre Z, Maruff P, Villemagne VL, Mengersen K, Rousseau J, White N, Doecke JD.

J Alzheimers Dis. 2020;73(2):683-693. doi: 10.3233/JAD-191095.

PMID:
31868673
6.

Harmonization of large MRI datasets for the analysis of brain imaging patterns throughout the lifespan.

Pomponio R, Erus G, Habes M, Doshi J, Srinivasan D, Mamourian E, Bashyam V, Nasrallah IM, Satterthwaite TD, Fan Y, Launer LJ, Masters CL, Maruff P, Zhuo C, Völzke H, Johnson SC, Fripp J, Koutsouleris N, Wolf DH, Gur R, Gur R, Morris J, Albert MS, Grabe HJ, Resnick SM, Bryan RN, Wolk DA, Shinohara RT, Shou H, Davatzikos C.

Neuroimage. 2020 Mar;208:116450. doi: 10.1016/j.neuroimage.2019.116450. Epub 2019 Dec 9.

7.

Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD.

Papp KV, Buckley R, Mormino E, Maruff P, Villemagne VL, Masters CL, Johnson KA, Rentz DM, Sperling RA, Amariglio RE; Collaborators from the Harvard Aging Brain Study, the Alzheimer's Disease Neuroimaging Initiative and the Australian Imaging, Biomarker and Lifestyle Study of Aging.

Alzheimers Dement. 2019 Nov 20. pii: S1552-5260(19)35446-9. doi: 10.1016/j.jalz.2019.09.074. [Epub ahead of print]

8.

Computerized cognitive performance assessments in the Brooklyn Cognitive Impairments in Health Disparities Pilot Study.

Adler K, Apple S, Friedlander A, Cheng F, Cohen C, Levine SR, Lucchesi M, Maruff P, Reinhardt M, Salmieri M, Stevens D, Weingast S, Gustafson D.

Alzheimers Dement. 2019 Nov;15(11):1420-1426. doi: 10.1016/j.jalz.2019.07.004.

9.

Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.

Burnham SC, Coloma PM, Li QX, Collins S, Savage G, Laws S, Doecke J, Maruff P, Martins RN, Ames D, Rowe CC, Masters CL, Villemagne VL.

J Prev Alzheimers Dis. 2019;6(4):248-255. doi: 10.14283/jpad.2019.25.

PMID:
31686097
10.

The impact of chemotherapy on cognitive function: a multicentre prospective cohort study in testicular cancer.

Whitford HS, Kalinowski P, Schembri A, Grimison P, Stockler M, Martin A, Toner GC, Davis ID, Maruff P, Olver IN; Australian and New Zealand Urogenital and Prostate Cancer Trials Group.

Support Care Cancer. 2019 Oct 23. doi: 10.1007/s00520-019-05095-3. [Epub ahead of print]

PMID:
31642990
11.

Associating Cognition With Amyloid Status Using Partially Ordered Set Analysis.

Carr SJA, Jaeger J, Bian S, He P, Maserejian N, Wang W, Maruff P, Enayetallah A, Wang Y, Chen Z, Lerner A, Tatsuoka C; Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing.

Front Neurol. 2019 Sep 13;10:976. doi: 10.3389/fneur.2019.00976. eCollection 2019.

12.

Use of an experimental language acquisition paradigm for standardized neuropsychological assessment of learning: A pilot study in young and older adults.

Baker JE, Bruns L Jr, Hassenstab J, Masters CL, Maruff P, Lim YY.

J Clin Exp Neuropsychol. 2020 Feb;42(1):55-65. doi: 10.1080/13803395.2019.1665626. Epub 2019 Sep 13.

PMID:
31514573
13.

The Effect of Cochlear Implants on Cognitive Function in Older Adults: Initial Baseline and 18-Month Follow Up Results for a Prospective International Longitudinal Study.

Sarant J, Harris D, Busby P, Maruff P, Schembri A, Dowell R, Briggs R.

Front Neurosci. 2019 Aug 2;13:789. doi: 10.3389/fnins.2019.00789. eCollection 2019.

14.

Indigenous traumatic brain injury research: responding to recruitment challenges in the hospital environment.

Fitts MS, Condon T, Gilroy J, Bird K, Bleakley E, Matheson L, Fleming J, Clough AR, Esterman A, Maruff P, Bohanna I.

BMC Med Res Methodol. 2019 Aug 7;19(1):172. doi: 10.1186/s12874-019-0813-x.

15.

Visual paired associate learning deficits associated with elevated beta-amyloid in cognitively normal older adults.

Baker JE, Pietrzak RH, Laws SM, Ames D, Villemagne VL, Rowe CC, Masters CL, Maruff P, Lim YY.

Neuropsychology. 2019 Oct;33(7):964-974. doi: 10.1037/neu0000561. Epub 2019 Aug 1.

PMID:
31368758
16.

Determining clinically meaningful decline in preclinical Alzheimer disease.

Insel PS, Weiner M, Mackin RS, Mormino E, Lim YY, Stomrud E, Palmqvist S, Masters CL, Maruff PT, Hansson O, Mattsson N.

Neurology. 2019 Jul 23;93(4):e322-e333. doi: 10.1212/WNL.0000000000007831. Epub 2019 Jul 9.

17.

Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype.

Vermunt L, Sikkes SAM, van den Hout A, Handels R, Bos I, van der Flier WM, Kern S, Ousset PJ, Maruff P, Skoog I, Verhey FRJ, Freund-Levi Y, Tsolaki M, Wallin ÅK, Olde Rikkert M, Soininen H, Spiru L, Zetterberg H, Blennow K, Scheltens P, Muniz-Terrera G, Visser PJ; Alzheimer Disease Neuroimaging Initiative; AIBL Research Group; ICTUS/DSA study groups.

Alzheimers Dement. 2019 Jul;15(7):888-898. doi: 10.1016/j.jalz.2019.04.001. Epub 2019 Jun 1.

PMID:
31164314
18.

COMT val158met is not associated with Aβ-amyloid and APOE ε4 related cognitive decline in cognitively normal older adults.

Porter T, Burnham SC, Milicic L, Savage G, Maruff P, Sohrabi HR, Peretti M, Lim YY, Weinborn M, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, Groth D, Verdile G, Villemagne VL, Laws SM.

IBRO Rep. 2019 May 2;6:147-152. doi: 10.1016/j.ibror.2019.05.001. eCollection 2019 Jun.

19.

The Vitamins in Psychosis Study: A Randomized, Double-Blind, Placebo-Controlled Trial of the Effects of Vitamins B12, B6, and Folic Acid on Symptoms and Neurocognition in First-Episode Psychosis.

Allott K, McGorry PD, Yuen HP, Firth J, Proffitt TM, Berger G, Maruff P, O'Regan MK, Papas A, Stephens TCB, O'Donnell CP.

Biol Psychiatry. 2019 Jul 1;86(1):35-44. doi: 10.1016/j.biopsych.2018.12.018. Epub 2019 Jan 9.

PMID:
30771856
20.

Klotho allele status is not associated with Aβ and APOE ε4-related cognitive decline in preclinical Alzheimer's disease.

Porter T, Burnham SC, Milicic L, Savage G, Maruff P, Lim YY, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, Groth D, Verdile G, Villemagne VL, Laws SM.

Neurobiol Aging. 2019 Apr;76:162-165. doi: 10.1016/j.neurobiolaging.2018.12.014. Epub 2019 Jan 6.

PMID:
30716541
21.

A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer's Disease.

Porter T, Burnham SC, Savage G, Lim YY, Maruff P, Milicic L, Peretti M, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, Taddei K, Groth D, Verdile G, Villemagne VL, Laws SM.

Front Aging Neurosci. 2018 Dec 19;10:423. doi: 10.3389/fnagi.2018.00423. eCollection 2018.

22.

Monitoring cognitive change in multiple sclerosis using a computerized cognitive battery.

De Meijer L, Merlo D, Skibina O, Grobbee EJ, Gale J, Haartsen J, Maruff P, Darby D, Butzkueven H, Van der Walt A.

Mult Scler J Exp Transl Clin. 2018 Dec 10;4(4):2055217318815513. doi: 10.1177/2055217318815513. eCollection 2018 Oct-Dec.

23.

Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementia.

Slot RER, Sikkes SAM, Berkhof J, Brodaty H, Buckley R, Cavedo E, Dardiotis E, Guillo-Benarous F, Hampel H, Kochan NA, Lista S, Luck T, Maruff P, Molinuevo JL, Kornhuber J, Reisberg B, Riedel-Heller SG, Risacher SL, Roehr S, Sachdev PS, Scarmeas N, Scheltens P, Shulman MB, Saykin AJ, Verfaillie SCJ, Visser PJ, Vos SJB, Wagner M, Wolfsgruber S, Jessen F; Alzheimer's Disease Neuroimaging Initiative; DESCRIPA working group; INSIGHT-preAD study group; SCD-I working group, van der Flier WM.

Alzheimers Dement. 2019 Mar;15(3):465-476. doi: 10.1016/j.jalz.2018.10.003. Epub 2018 Dec 13.

24.

Reduced professional efficacy is associated with a blunted salivary alpha-amylase awakening response.

Landolt K, Maruff P, Horan B, Kingsley M, Kinsella G, O'Halloran PD, Hale MW, Wright BJ.

Physiol Behav. 2019 Feb 1;199:292-299. doi: 10.1016/j.physbeh.2018.11.038. Epub 2018 Nov 29.

PMID:
30503848
25.

Necessity of technicians for computerized neuropsychological assessment devices in multiple sclerosis.

Wojcik CM, Rao SM, Schembri AJ, Drake AS, Maruff P, Schindler D, Alberts J, Yasin F, Pol J, Weinstock-Guttman B, Benedict RH.

Mult Scler. 2020 Jan;26(1):109-113. doi: 10.1177/1352458518813287. Epub 2018 Nov 22.

PMID:
30465463
26.

Incidence of emergency department presentations for traumatic brain injury in Indigenous and non-Indigenous residents aged 15-64 over the 9-year period 2007-2015 in North Queensland, Australia.

Esterman A, Thompson F, Fitts M, Gilroy J, Fleming J, Maruff P, Clough A, Bohanna I.

Inj Epidemiol. 2018 Nov 12;5(1):40. doi: 10.1186/s40621-018-0172-9.

27.

Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.

Porter T, Burnham SC, Milicic L, Savage G, Maruff P, Lim YY, Li QX, Ames D, Masters CL, Rainey-Smith S, Rowe CC, Salvado O, Groth D, Verdile G, Villemagne VL, Laws SM; AIBL Research Group.

J Alzheimers Dis. 2018;66(3):1193-1211. doi: 10.3233/JAD-180713.

PMID:
30412495
28.

Unsupervised online neuropsychological test performance for individuals with mild cognitive impairment and dementia: Results from the Brain Health Registry.

Mackin RS, Insel PS, Truran D, Finley S, Flenniken D, Nosheny R, Ulbright A, Comacho M, Bickford D, Harel B, Maruff P, Weiner MW.

Alzheimers Dement (Amst). 2018 Jun 21;10:573-582. doi: 10.1016/j.dadm.2018.05.005. eCollection 2018.

29.

Online study partner-reported cognitive decline in the Brain Health Registry.

Nosheny RL, Camacho MR, Insel PS, Flenniken D, Fockler J, Truran D, Finley S, Ulbricht A, Maruff P, Yaffe K, Mackin RS, Weiner MW.

Alzheimers Dement (N Y). 2018 Oct 15;4:565-574. doi: 10.1016/j.trci.2018.09.008. eCollection 2018.

30.

Mediterranean diet adherence and rate of cerebral Aβ-amyloid accumulation: Data from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing.

Rainey-Smith SR, Gu Y, Gardener SL, Doecke JD, Villemagne VL, Brown BM, Taddei K, Laws SM, Sohrabi HR, Weinborn M, Ames D, Fowler C, Macaulay SL, Maruff P, Masters CL, Salvado O, Rowe CC, Scarmeas N, Martins RN.

Transl Psychiatry. 2018 Oct 30;8(1):238. doi: 10.1038/s41398-018-0293-5.

31.

Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer's disease: results of a randomized, double-blind, placebo-controlled phase 2a study.

Scheltens P, Hallikainen M, Grimmer T, Duning T, Gouw AA, Teunissen CE, Wink AM, Maruff P, Harrison J, van Baal CM, Bruins S, Lues I, Prins ND.

Alzheimers Res Ther. 2018 Oct 12;10(1):107. doi: 10.1186/s13195-018-0431-6.

32.

Similar neurocognitive outcomes after 48 weeks in HIV-1-infected participants randomized to continue tenofovir/emtricitabine + atazanavir/ritonavir or simplify to abacavir/lamivudine + atazanavir.

Robertson K, Maruff P, Ross LL, Wohl D, Small CB, Edelstein H, Shaefer MS.

J Neurovirol. 2019 Feb;25(1):22-31. doi: 10.1007/s13365-018-0680-y. Epub 2018 Oct 8.

33.

Superior Memory Reduces 8-year Risk of Mild Cognitive Impairment and Dementia But Not Amyloid β-Associated Cognitive Decline in Older Adults.

Dang C, Harrington KD, Lim YY, Ames D, Hassenstab J, Laws SM, Yassi N, Hickey M, Rainey-Smith SR, Robertson J, Rowe CC, Sohrabi HR, Salvado O, Weinborn M, Villemagne VL, Masters CL, Maruff P; AIBL Research Group.

Arch Clin Neuropsychol. 2019 Jul 26;34(5):585-598. doi: 10.1093/arclin/acy078.

PMID:
30272115
34.

The relationship between depression and cognitive function in adults with cardiovascular risk: Evidence from a randomised attention-controlled trial.

LaMonica HM, Biddle DJ, Naismith SL, Hickie IB, Maruff P, Glozier N.

PLoS One. 2018 Sep 5;13(9):e0203343. doi: 10.1371/journal.pone.0203343. eCollection 2018.

35.

Total Sleep Time Interacts With Age to Predict Cognitive Performance Among Adults.

Mohlenhoff BS, Insel PS, Mackin RS, Neylan TC, Flenniken D, Nosheny R, Richards A, Maruff P, Weiner MW.

J Clin Sleep Med. 2018 Sep 15;14(9):1587-1594. doi: 10.5664/jcsm.7342.

36.

The wake maintenance zone shows task dependent changes in cognitive function following one night without sleep.

McMahon WR, Ftouni S, Drummond SPA, Maruff P, Lockley SW, Rajaratnam SMW, Anderson C.

Sleep. 2018 Oct 1;41(10). doi: 10.1093/sleep/zsy148.

PMID:
30169703
37.

Relationship Between Amyloid-β Positivity and Progression to Mild Cognitive Impairment or Dementia over 8 Years in Cognitively Normal Older Adults.

Dang C, Harrington KD, Lim YY, Ames D, Hassenstab J, Laws SM, Yassi N, Hickey M, Rainey-Smith S, Robertson J, Sohrabi HR, Salvado O, Weinborn M, Villemagne VL, Rowe CC, Masters CL, Maruff P; AIBL Research Group.

J Alzheimers Dis. 2018;65(4):1313-1325. doi: 10.3233/JAD-180507.

PMID:
30149452
38.

Episodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease.

Baker JE, Lim YY, Jaeger J, Ames D, Lautenschlager NT, Robertson J, Pietrzak RH, Snyder PJ, Villemagne VL, Rowe CC, Masters CL, Maruff P.

J Alzheimers Dis. 2018;65(3):977-988. doi: 10.3233/JAD-180344.

PMID:
30103330
39.

Estimates of age-related memory decline are inflated by unrecognized Alzheimer's disease.

Harrington KD, Schembri A, Lim YY, Dang C, Ames D, Hassenstab J, Laws SM, Rainey-Smith S, Robertson J, Rowe CC, Sohrabi HR, Salvado O, Weinborn M, Villemagne VL, Masters CL, Maruff P; AIBL Research Group.

Neurobiol Aging. 2018 Oct;70:170-179. doi: 10.1016/j.neurobiolaging.2018.06.005. Epub 2018 Jun 11.

PMID:
30015036
40.

Effect of BDNFVal66Met on disease markers in dominantly inherited Alzheimer's disease.

Lim YY, Hassenstab J, Goate A, Fagan AM, Benzinger TLS, Cruchaga C, McDade E, Chhatwal J, Levin J, Farlow MR, Graff-Radford NR, Laske C, Masters CL, Salloway S, Schofield P, Morris JC, Maruff P, Bateman RJ; Dominantly Inherited Alzheimer Network.

Ann Neurol. 2018 Sep;84(3):424-435. doi: 10.1002/ana.25299. Epub 2018 Aug 25.

41.

Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts.

Buckley RF, Mormino EC, Amariglio RE, Properzi MJ, Rabin JS, Lim YY, Papp KV, Jacobs HIL, Burnham S, Hanseeuw BJ, Doré V, Dobson A, Masters CL, Waller M, Rowe CC, Maruff P, Donohue MC, Rentz DM, Kirn D, Hedden T, Chhatwal J, Schultz AP, Johnson KA, Villemagne VL, Sperling RA; Alzheimer's Disease Neuroimaging Initiative; Australian Imaging, Biomarker and Lifestyle study of ageing; Harvard Aging Brain Study.

Alzheimers Dement. 2018 Sep;14(9):1193-1203. doi: 10.1016/j.jalz.2018.04.010. Epub 2018 May 24.

42.

Trajectories of irregular word reading ability as a proxy for premorbid intelligence in Alzheimer's disease, mild cognitive impairment, and healthy aging: A longitudinal study.

Weinborn M, Bucks RS, Sohrabi HR, Rainey-Smith SR, Brown BM, Gardener SL, Gozt A, Christensen D, Savage G, Laws SM, Taddei K, Maruff P, Robertson JS, Ellis KA, Ames D, Masters CL, Rowe CC, Martins RN.

Psychol Assess. 2018 Oct;30(10):1308-1316. doi: 10.1037/pas0000565. Epub 2018 May 21.

43.

The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable.

Knopman DS, Haeberlein SB, Carrillo MC, Hendrix JA, Kerchner G, Margolin R, Maruff P, Miller DS, Tong G, Tome MB, Murray ME, Nelson PT, Sano M, Mattsson N, Sultzer DL, Montine TJ, Jack CR Jr, Kolb H, Petersen RC, Vemuri P, Canniere MZ, Schneider JA, Resnick SM, Romano G, van Harten AC, Wolk DA, Bain LJ, Siemers E.

Alzheimers Dement. 2018 Apr;14(4):563-575. doi: 10.1016/j.jalz.2018.03.002. Review.

44.

Baseline Amnestic Severity Predicts Progression From Amnestic Mild Cognitive Impairment to Alzheimer Disease Dementia at 3 Years.

Bradfield NI, Ellis KA, Savage G, Maruff P, Burnham S, Darby D, Lautenschlager NT, Martins RN, Masters CL, Rainey-Smith SR, Robertson J, Rowe C, Woodward M, Ames D.

Alzheimer Dis Assoc Disord. 2018 Jul-Sep;32(3):190-196. doi: 10.1097/WAD.0000000000000252.

PMID:
29561277
45.

Cognitive Function Before and After Left Heart Catheterization.

Scott DA, Evered L, Maruff P, MacIsaac A, Maher S, Silbert BS.

J Am Heart Assoc. 2018 Mar 10;7(6). pii: e008004. doi: 10.1161/JAHA.117.008004.

46.

Genetic variation in Aquaporin-4 moderates the relationship between sleep and brain Aβ-amyloid burden.

Rainey-Smith SR, Mazzucchelli GN, Villemagne VL, Brown BM, Porter T, Weinborn M, Bucks RS, Milicic L, Sohrabi HR, Taddei K, Ames D, Maruff P, Masters CL, Rowe CC, Salvado O, Martins RN, Laws SM; AIBL Research Group.

Transl Psychiatry. 2018 Feb 26;8(1):47. doi: 10.1038/s41398-018-0094-x.

47.

KIBRA is associated with accelerated cognitive decline and hippocampal atrophy in APOE ε4-positive cognitively normal adults with high Aβ-amyloid burden.

Porter T, Burnham SC, Doré V, Savage G, Bourgeat P, Begemann K, Milicic L, Ames D, Bush AI, Maruff P, Masters CL, Rowe CC, Rainey-Smith S, Martins RN, Groth D, Verdile G, Villemagne VL, Laws SM.

Sci Rep. 2018 Feb 1;8(1):2034. doi: 10.1038/s41598-018-20513-y.

48.

Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-β.

Fernando WMADB, Rainey-Smith SR, Gardener SL, Villemagne VL, Burnham SC, Macaulay SL, Brown BM, Gupta VB, Sohrabi HR, Weinborn M, Taddei K, Laws SM, Goozee K, Ames D, Fowler C, Maruff P, Masters CL, Salvado O, Rowe CC, Martins RN; AIBL Research Group.

J Alzheimers Dis. 2018;61(4):1589-1598. doi: 10.3233/JAD-170742.

PMID:
29376865
49.

Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease.

Lim YY, Kalinowski P, Pietrzak RH, Laws SM, Burnham SC, Ames D, Villemagne VL, Fowler CJ, Rainey-Smith SR, Martins RN, Rowe CC, Masters CL, Maruff PT.

JAMA Neurol. 2018 Apr 1;75(4):488-494. doi: 10.1001/jamaneurol.2017.4325.

50.

Amyloid burden and incident depressive symptoms in preclinical Alzheimer's disease.

Perin S, Harrington KD, Lim YY, Ellis K, Ames D, Pietrzak RH, Schembri A, Rainey-Smith S, Salvado O, Laws SM, Martins RN, Villemagne VL, Rowe CC, Masters CL, Maruff P; AIBL research group.

J Affect Disord. 2018 Mar 15;229:269-274. doi: 10.1016/j.jad.2017.12.101. Epub 2018 Jan 3.

PMID:
29329059

Supplemental Content

Loading ...
Support Center